Bernhard Hemmer
#138,820
Most Influential Person Now
Researcher
Bernhard Hemmer's AcademicInfluence.com Rankings
Bernhard Hemmerbiology Degrees
Biology
#9700
World Rank
#12935
Historical Rank
Genetics
#996
World Rank
#1093
Historical Rank
Molecular Biology
#1347
World Rank
#1374
Historical Rank
Neuroscience
#1433
World Rank
#1483
Historical Rank
Download Badge
Biology
Bernhard Hemmer's Degrees
- PhD Neuroscience University of Zurich
- Masters Biology University of Zurich
- Bachelors Biology University of Zurich
Similar Degrees You Can Earn
Why Is Bernhard Hemmer Influential?
(Suggest an Edit or Addition)Bernhard Hemmer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) (2511)
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis (2017) (1170)
- Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis (2017) (1107)
- An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis (2012) (893)
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking (2009) (618)
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients (2012) (598)
- Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) (589)
- New concepts in the immunopathogenesis of multiple sclerosis (2002) (585)
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica (2009) (517)
- Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. (2006) (498)
- Multiple sclerosis (2018) (497)
- TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways (2003) (466)
- Immune surveillance in multiple sclerosis patients treated with natalizumab (2006) (435)
- EFNS guidelines on diagnosis and management of neuromyelitis optica (2010) (414)
- Role of the innate and adaptive immune responses in the course of multiple sclerosis (2015) (402)
- Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone (1997) (355)
- Potassium channel KIR4.1 as an immune target in multiple sclerosis. (2012) (341)
- Acute disseminated encephalomyelitis: an update. (2005) (340)
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis (2018) (319)
- Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. (2005) (316)
- Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis (2017) (310)
- Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses (2016) (287)
- Immunopathogenesis and immunotherapy of multiple sclerosis (2006) (269)
- Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease (2009) (266)
- Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. (2006) (263)
- Class II HLA interactions modulate genetic risk for multiple sclerosis (2015) (262)
- Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. (2002) (258)
- γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. (2010) (251)
- Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis (2006) (241)
- Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE (2011) (239)
- Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease (1999) (235)
- Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. (2001) (230)
- A PD‐1 polymorphism is associated with disease progression in multiple sclerosis (2005) (220)
- A point mutation in PTPRC is associated with the development of multiple sclerosis (2000) (208)
- Trans-presentation of interleukin-6 by dendritic cells is required for priming pathogenic TH17 cells (2016) (205)
- Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system (2004) (201)
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis (2010) (200)
- Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. (2005) (198)
- Consensus guidelines for lumbar puncture in patients with neurological diseases (2017) (197)
- Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study (2013) (194)
- The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. (2011) (189)
- CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation (2012) (185)
- Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. (1998) (184)
- Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. (2008) (183)
- Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. (1998) (182)
- Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease (2002) (181)
- Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis (2005) (170)
- Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS (2020) (156)
- Simultaneous Electroencephalographic and Functional Magnetic Resonance Imaging Indicate Impaired Cortical Top–Down Processing in Association with Anesthetic-induced Unconsciousness (2013) (156)
- Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. (2005) (151)
- Probing degeneracy in T-cell recognition using peptide combinatorial libraries. (1998) (151)
- Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. (2013) (149)
- Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. (1999) (146)
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS (2011) (146)
- Spatiotemporal Reconfiguration of Large-Scale Brain Functional Networks during Propofol-Induced Loss of Consciousness (2012) (137)
- Acute disseminated encephalomyelitis: an acute hit against the brain (2007) (136)
- Pathogenesis of multiple sclerosis: an update on immunology (2002) (134)
- Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy (2009) (134)
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis (2013) (129)
- Cell-based therapeutic strategies for multiple sclerosis (2017) (128)
- The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. (2010) (120)
- B lymphocytes in neuromyelitis optica (2015) (118)
- Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? (2010) (117)
- DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis (2018) (116)
- Cerebrospinal fluid biomarkers in multiple sclerosis (2009) (116)
- Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. (2006) (115)
- The role of antibodies in multiple sclerosis. (2011) (115)
- The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility (2017) (113)
- Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms (2020) (113)
- Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. (2006) (112)
- Progressive multifocal leukoencephalopathy after fingolimod treatment (2018) (111)
- Molecular mimicry and multiple sclerosis: Degenerate T‐cell recognition and the induction of autoimmunity (1999) (111)
- Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response (2017) (110)
- Combinatorial Peptide Libraries and Biometric Score Matrices Permit the Quantitative Analysis of Specific and Degenerate Interactions Between Clonotypic TCR and MHC Peptide Ligands1 (2001) (109)
- Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. (1997) (109)
- Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. (1997) (104)
- Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation (2016) (104)
- Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99) (1996) (103)
- Apheresis therapies for NMOSD attacks (2018) (103)
- Etiology and site of temporal lobe epilepsy influence postictal cytokine release (2009) (102)
- Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis (2010) (99)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (98)
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH 17 cells (98)
- The 11-year long-term follow-up study from the randomized BENEFIT CIS trial (2016) (97)
- Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort (2013) (96)
- EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units (2011) (94)
- TNF-alpha induced NFκB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells. (2012) (91)
- Neurofilament ELISA validation. (2010) (90)
- IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1 (2014) (90)
- Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis (2019) (89)
- Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. (2010) (89)
- HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis (2008) (88)
- Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis (2005) (86)
- Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study. (2016) (85)
- Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. (2016) (84)
- Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. (2009) (81)
- Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders (2019) (81)
- The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. (2009) (80)
- Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands. (1999) (78)
- Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis (2010) (78)
- The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. (2003) (77)
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2019) (77)
- Toward the development of rational therapies in multiple sclerosis: what is on the horizon? (2007) (76)
- Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis (2016) (76)
- Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety (2015) (74)
- EFNS guidelines on disease‐specific CSF investigations (2009) (74)
- Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination (2016) (74)
- Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro (2005) (74)
- Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. (2001) (74)
- Contribution of Individual Amino Acids Within MHC Molecule or Antigenic Peptide to TCR Ligand Potency1 (2000) (73)
- IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci (2010) (72)
- Requirement for safety monitoring for approved multiple sclerosis therapies: an overview (2014) (71)
- Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survival. (2000) (71)
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders (2011) (70)
- Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases (2019) (68)
- Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. (2007) (68)
- Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study (2019) (67)
- Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies (2011) (66)
- Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis (2011) (65)
- Interictal alterations of cytokines and leukocytes in patients with active epilepsy (2011) (64)
- The Genetic Association of Variants in CD6, TNFRSF1A and IRF8 to Multiple Sclerosis: A Multicenter Case-Control Study (2011) (64)
- Impact of HMG-CoA reductase inhibition on brain pathology. (2007) (64)
- White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI (2013) (63)
- Treatment of multiple sclerosis: current concepts and future perspectives (2011) (62)
- Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study (2015) (62)
- Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases (2013) (62)
- Acyclovir resistance in herpes simplex encephalitis (2010) (62)
- Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis. (2013) (61)
- Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones (1998) (61)
- T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells (1997) (60)
- Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis. (2011) (60)
- Boxing-acute complications and late sequelae: from concussion to dementia. (2010) (60)
- Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome (2018) (60)
- Active Immunization with Amyloid-β 1–42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System (2010) (59)
- Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. (2015) (59)
- NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy (2008) (59)
- High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis (2005) (58)
- Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83–99) (1996) (58)
- Cortical pathology in multiple sclerosis detected by the T1/T2‐weighted ratio from routine magnetic resonance imaging (2017) (57)
- Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein. (1997) (56)
- Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects. (2012) (56)
- Treatment and treatment trials in multiple sclerosis (2007) (55)
- Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging (2019) (54)
- MRI Plaque Imaging Detects Carotid Plaques with a High Risk for Future Cerebrovascular Events in Asymptomatic Patients (2013) (54)
- Influence of female sex and fertile age on neuromyelitis optica spectrum disorders (2016) (53)
- Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases (2010) (53)
- Atrophy and structural variability of the upper cervical cord in early multiple sclerosis (2015) (53)
- Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica (2011) (52)
- Myeloid-derived suppressor cells control B cell accumulation in the CNS during autoimmunity (2018) (52)
- Effect of minocycline in experimental autoimmune encephalomyelitis (2002) (51)
- Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis (2020) (51)
- Varicella zoster virus is not a disease‐relevant antigen in multiple sclerosis (2009) (51)
- Accumulation of class switched IgD−IgM− memory B cells in the cerebrospinal fluid during neuroinflammation (2006) (51)
- Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study (2020) (51)
- The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model (2015) (49)
- Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. (2007) (49)
- Lack of association with TorsinA haplotype in German patients with sporadic dystonia (2006) (49)
- CNS Aquaporin‐4‐specific B cells connect with multiple B‐cell compartments in neuromyelitis optica spectrum disorder (2017) (48)
- Neuromyelitis optica following human papillomavirus vaccination (2012) (48)
- Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) (48)
- Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients (2017) (48)
- Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist — A putative role for substance P in CNS inflammation (2006) (48)
- Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. (2000) (48)
- Effects of interferon-β on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-β treatment in patients with multiple sclerosis (2008) (47)
- Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions (2014) (47)
- Cortical pathology in MS detected by the T1/T2-weighted ratio from routine MRI (2017) (47)
- Multiple sclerosis – novel insights and new therapeutic strategies (2005) (46)
- Pharmacological Treatment of Early Multiple Sclerosis (2008) (46)
- The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations (2015) (45)
- Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis. (2010) (45)
- MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis (2010) (45)
- A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule (2002) (45)
- Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis. (2015) (45)
- Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis. (2009) (45)
- PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter? (2016) (45)
- Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis (2007) (44)
- Disease-Modifying Agents for Multiple Sclerosis (2012) (44)
- Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype (1997) (43)
- Severe multiple sclerosis relapse under fingolimod therapy: Incident or coincidence? (2012) (43)
- Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients (2011) (43)
- Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis. (2019) (42)
- Multiple sclerosis -- a coordinated immune attack across the blood brain barrier. (2004) (42)
- Persistence of immunopathological and radiological traits in multiple sclerosis. (2008) (42)
- Mitochondrial membrane protein associated neurodegenration: A novel variant of neurodegeneration with brain iron accumulation (2013) (42)
- Multiple sclerosis and the autonomic nervous system (2006) (42)
- Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease (2014) (42)
- Prevalence of neuropathic pain in early multiple sclerosis (2016) (42)
- The radiologically isolated syndrome: take action when the unexpected is uncovered? (2010) (41)
- IL 12 A , MPHOSPH 9 / CDK 2 AP 1 and RGS 1 are novel multiple sclerosis susceptibility loci (2010) (41)
- Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis (2006) (41)
- 18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions (2012) (41)
- To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis (2014) (40)
- Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis. (2009) (39)
- Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. (2019) (39)
- Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity (2016) (38)
- Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis (2013) (38)
- EASY-HIT: HIV Full-Replication Technology for Broad Discovery of Multiple Classes of HIV Inhibitors (2010) (37)
- Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients (2013) (37)
- A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (36)
- The neuropathology of fatal encephalomyelitis in human Borna virus infection (2019) (36)
- Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling (2010) (35)
- Clonal accumulation of activated CD8+ T cells in the central nervous system during the early phase of neuroborreliosis. (2003) (35)
- Current and future therapies targeting the immune system in multiple sclerosis. (2014) (34)
- Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results (2017) (34)
- DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning (2018) (34)
- Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters (2018) (34)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (33)
- In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica‐related pathology (2016) (33)
- Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis (2017) (33)
- The use of soluble synthetic peptide combinatorial libraries to determine antigen recognition of T cells. (2009) (33)
- B cell-directed therapies in multiple sclerosis. (2016) (32)
- Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders (2014) (32)
- From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis (2017) (32)
- Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses (2020) (32)
- Power estimation for non-standardized multisite studies (2016) (31)
- Aggressive multiple sclerosis (1): Towards a definition of the phenotype (2020) (30)
- Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report. (2007) (30)
- Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease (2010) (29)
- High throughput analysis of TCR-β rearrangement and gene expression in single T cells (2006) (29)
- Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity (2020) (29)
- A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015 (2018) (29)
- CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date (2019) (28)
- High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study (2009) (28)
- New immunopathologic insights into multiple sclerosis (2003) (28)
- Lesion patterns in patients with cryptogenic stroke with and without right‐to‐left‐shunt (2009) (27)
- Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey (2021) (27)
- More CLEC16A gene variants associated with multiple sclerosis (2011) (26)
- α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets (2014) (26)
- Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response (2012) (26)
- A large case-control study on vaccination as risk factor for multiple sclerosis (2019) (26)
- Vitamin D, smoking, EBV, and long-term cognitive performance in MS (2020) (26)
- Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta. (2010) (25)
- Optimal Inter-Eye Difference Thresholds by OCT in MS: An International Study (2019) (25)
- Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS) (2018) (25)
- Central nervous system infections - a potential complication of systemic immunotherapy. (2006) (25)
- Primary central nervous system lymphoma in a patient treated with natalizumab (2009) (24)
- Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis (2005) (24)
- Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis. (2008) (24)
- Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. (2020) (23)
- Prognostic value of the ABCD2 score beyond short-term follow-up after transient ischemic attack (TIA) - a cohort study (2010) (23)
- The Combination of Interferon‐Beta and HMG‐CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon? (2010) (23)
- Gene expression profiles derived from single cells in human postmortem brain. (2004) (23)
- Viral load determines the B‐cell response in the cerebrospinal fluid during human immunodeficiency virus infection (2007) (23)
- Degeneracy in T-cell antigen recognition – implications for the pathogenesis of autoimmune diseases (2000) (22)
- Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity (2014) (22)
- CD45 Isoform Expression in Autoimmune Myasthenia Gravis (2003) (22)
- Update on immunopathogenesis and immunotherapy in multiple sclerosis (2013) (22)
- Patent foramen ovale is not associated with an increased risk of stroke recurrence (2010) (21)
- A call for a global COVID-19 Neuro Research Coalition (2020) (21)
- Myoclonus‐dystonia in 18p deletion syndrome (2011) (21)
- The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion (2016) (21)
- Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium (2020) (20)
- Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis. (2008) (19)
- New approaches to dissect degeneracy and specificity in T cell antigen recognition (2001) (19)
- Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms (2020) (19)
- Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta (2013) (18)
- Efficacy and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis: Results of the Phase III Double-Blind, Placebo-Controlled ORATORIO Study (S49.001) (2016) (18)
- Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study (2016) (18)
- Translational research in neurology and neuroscience 2010: multiple sclerosis. (2010) (18)
- Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis (2010) (18)
- Dynamics of Intracranial Venous Flow Patterns in Patients with Idiopathic Intracranial Hypertension (2011) (18)
- Skin and gut imprinted T helper cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity (2021) (17)
- Human T lymphocytes specific for the immunodominant 83–99 epitope of myelin basic protein: Recognition of golli MBP HOG 7 (1996) (17)
- Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array (2015) (17)
- Decrypting the spectrum of antigen‐specific T‐cell responses: the avidity repertoire of MBP‐specific T‐cells (2000) (17)
- Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis (2018) (17)
- Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis (2005) (16)
- Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. (2013) (16)
- Validation of Plasma Branched Chain Amino Acids as Biomarkers in Huntington Disease (2017) (16)
- Anti-JC-virus antibody prevalence in a German MS cohort (2012) (16)
- Pearls & Oy-sters: Cerebral HSV-2 vasculitis presenting as hemorrhagic stroke followed by multifocal ischemia (2012) (16)
- Novel monoclonal antibodies for therapy of multiple sclerosis (2014) (16)
- Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy (2020) (16)
- CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals. (2007) (15)
- Viral pathogens in multiple sclerosis: an intriguing (hi)story. (2004) (15)
- Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates (2015) (15)
- Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis. (2004) (15)
- Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity (2013) (15)
- Specificity and degeneracy: T cell recognition in CNS autoimmunity. (2004) (15)
- Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis (2020) (15)
- Molecular mimicry and multiple sclerosis--a possible role for degenerate T cell recognition in the induction of autoimmune responses. (1999) (15)
- Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients (2021) (15)
- Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses (2010) (15)
- Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain–Barré syndrome (2016) (15)
- Optical coherence tomography angiography indicates subclinical retinal disease in neuromyelitis optica spectrum disorders (2021) (14)
- Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab (2020) (14)
- Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients. (2018) (14)
- Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease. (2000) (14)
- Aggressive multiple sclerosis (2): Treatment (2020) (14)
- Cerebral vasculitis mimicking migraine with aura in a patient with Crohn's disease. (2009) (14)
- Predictive value of transcranial evoked potentials during mechanical endovascular therapy for acute ischaemic stroke: a feasibility study (2015) (14)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2020) (13)
- Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients (2020) (13)
- Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid (2004) (13)
- COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients (2021) (12)
- Immunosuppressive Treatment of Ocular Myasthenia Gravis (2012) (12)
- The spectrum of aseptic central nervous system infections in southern Germany – demographic, clinical and laboratory findings (2017) (12)
- The antibody response to oligodendrocyte specific protein in multiple sclerosis (2010) (12)
- The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis (2013) (12)
- Revised criteria for neuromyelitis optica—a new diagnostic standard? (2007) (12)
- CSF parameters associated with early MRI activity in patients with MS (2019) (12)
- Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study (2019) (12)
- Code Stroke Patient Referral by Emergency Medical Services During the Public COVID-19 Pandemic Lockdown (2020) (12)
- Biomarkers of treatment response in multiple sclerosis (2014) (12)
- Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption (2013) (12)
- Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination (2022) (12)
- The Value of the Serum Neurofilament Protein Heavy Chain as a Biomarker for Peri-operative Brain Injury After Carotid Endarterectomy (2009) (12)
- Mobilization of CD133+ Progenitor Cells in Patients with Acute Cerebral Infarction (2014) (11)
- Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue (2021) (11)
- Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab “infusion group” (2013) (11)
- Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients. (2017) (11)
- The role of the Epstein–Barr Virus receptor CD21 in Multiple Sclerosis (2012) (10)
- Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis. (2021) (10)
- Efficacy of ocrelizumab in patients with PPMS with and without T1 gadolinium-enhancing lesions at baseline in a Phase III, placebo-controlled trial (2016) (10)
- Autosomal dominant congenital nystagmus is not linked to 6p12, 7p11, and 15q11 in a German family. (2004) (10)
- Multiple sclerosis in 2016: Immune-directed therapies in MS — efficacy and limitations (2017) (10)
- Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis (2021) (10)
- Siponimod Inhibits the Formation of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis (2021) (9)
- Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis (2021) (9)
- Boxing—Acute Complications and Late Sequelae (2010) (9)
- Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies—conflicting results? (2015) (9)
- Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS (2020) (9)
- Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation (2006) (8)
- Thyroid antibodies in aquaporin‐4 antibody positive central nervous system autoimmunity and multiple sclerosis (2011) (8)
- Isolation, Culture and Functional Characterization of Glia and Endothelial Cells From Adult Pig Brain (2019) (8)
- A 32-year-old man with relapsing-progressive brainstem symptoms (2006) (8)
- Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age (2008) (8)
- Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials (2019) (8)
- Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity (2018) (8)
- Transcranial Doppler ultrasonography predicts cardiovascular events after TIA (2009) (8)
- Myositis in a patient with large granular leukocyte leukemia (2004) (8)
- Is APOE ε4 associated with cognitive performance in early MS? (2020) (8)
- HLA Genetic Risk Burden in Multiple Sclerosis. (2016) (8)
- Nerve conduction velocity is regulated by the inositol polyphosphate-4-phosphatase II gene. (2014) (8)
- Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis (2019) (8)
- The role of the Polio Virus Receptor and the Herpesvirus entry mediator B genes for the development of MS (2004) (8)
- Ethical use of off-label disease-modifying therapies for multiple sclerosis (2021) (7)
- Surface expression of CXCR4 on circulating CD133+ progenitor cells is associated with plaque instability in subjects with carotid artery stenosis (2009) (7)
- Failure of alemtuzumab as a rescue in a NMOSD patient treated with rituximab (2016) (7)
- The Aryl Hydrocarbon Receptor–Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis (2021) (7)
- NR 1 H 3 p . Arg 415 Gln is not associated to multiple sclerosis risk (2018) (7)
- Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion? (2019) (6)
- COVID-19-associated Large Vessel Stroke in a 28-year-old Patient (2021) (6)
- The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis (2007) (6)
- Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS (2020) (6)
- Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis. (2019) (6)
- Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide (2011) (6)
- The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis (2022) (6)
- Short commentary on ‘a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking’ (2010) (6)
- COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients Case Series (6)
- Enriched CD 161 high CCR 6 T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis (2013) (6)
- Sibling disability risk at onset and during disease progression in familial multiple sclerosis (2011) (6)
- Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis (2014) (5)
- Baseline Demographics and Disease Characteristics from ORATORIO, a Phase III Trial Evaluating Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis (P7.017) (2015) (5)
- Should we measure the bioavailability of interferon β in vivo in patients with multiple sclerosis? (2009) (5)
- [Radiologically isolated syndrome: multiple sclerosis based solely on MRI findings?]. (2010) (5)
- Dynamics of Retinal Vessel Loss After Acute Optic Neuritis in Patients With Relapsing Multiple Sclerosis (2022) (5)
- Correction: Corrigendum: Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells (2017) (5)
- A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitors. (2011) (5)
- Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report (2015) (5)
- Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability (2022) (5)
- ECTRIMS-EAN clinical practice guideline on pharmacological management of multiple sclerosis. (2016) (5)
- No association of three polymorphisms in the alpha-2-macroglobulin and lipoprotein related receptor genes with multiple sclerosis (2001) (5)
- Association of obesity with disease outcome in multiple sclerosis (2022) (5)
- Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6. (2012) (5)
- Clinical trials in multiple sclerosis: potential future trial designs (2019) (5)
- Genetic determinants of the humoral immune response in MS (2020) (5)
- Antibodies to aquaporin-4 in patients with a clinically isolated syndrome: analysis from the BENEFIT study (2008) (4)
- High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes. (2007) (4)
- Immunological and clinical status 14 months after cessation of natalizumab therapy (2008) (4)
- Clinicopathological considerations in acute disseminated encephalomyelitis (ADEM): a fulminant case with favorable outcome (2012) (4)
- DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis (2018) (4)
- BAF312, a Selective Sphingosine 1-Phosphate Receptor Modulator, Effectively Suppresses MRI Lesion Activity in Relapsing-Remitting Multiple Sclerosis: Findings of an Adaptive Dose-Ranging Phase 2 Study (2011) (4)
- Glucocerebrosidase Mutations and Risk of Parkinson Disease in Chinese Patients (2007) (4)
- Differential glycosylation of KIR4.1 in glial cells affects binding of autoantibodies in multiple sclerosis (2014) (4)
- Operation modes of series inverter 400 kHz for induction heating (2002) (4)
- [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. (2019) (4)
- Association of peripapillary hyper‐reflective ovoid masslike structures and disease duration in primary progressive multiple sclerosis (2021) (4)
- From the prodromal stage of multiple sclerosis to disease prevention (2022) (4)
- A new form of axonal pathology in a spinal model of neuromyelitis optica (2022) (4)
- Genetic variants associated with intrathecal synthesis of IgG, IgM and IgA in multiple sclerosis (2016) (3)
- Combined Treatment With Pembrolizumab and Allogenic BK Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy (2021) (3)
- BAF312, a Selective Sphingosine-1-Phosphate Receptor Modulator Improves MRI and Clinical Outcomes in Relapsing-Remitting Multiple Sclerosis (RRMS) (S30.001) (2012) (3)
- Consensus guidelines to perform lumbar puncture for CSF sampling in patients with neurological conditions (2015) (3)
- Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS (2020) (3)
- Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort (2022) (3)
- Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis 1 / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking (2010) (3)
- Phase 2 BOLD Extension Study Safety Results for Siponimod (BAF312) in Patients with Relapsing–Remitting Multiple Sclerosis (P01.176) (2013) (3)
- Analysis of the Stathmin rs182455 Single Nucleotide Promoter Polymorphism in Patients with Multiple Sclerosis (2008) (3)
- The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021 (2022) (3)
- Daclizumab for the treatment of relapsing-remitting multiple sclerosis (2017) (3)
- Systemic thrombolysis in ischemic stroke after recent oral surgery and management of oral cavity bleeding. (2011) (3)
- Vaccination in B-cell–depleted patients with multiple sclerosis (2020) (3)
- Vaccination in B-cell depleted MS patients. (2020) (3)
- Hunting for autoantibodies in multiple sclerosis (2013) (3)
- Extensive Recruitment of Plasma Blasts to the Cerebrospinal Fluid in Toscana Virus Encephalitis (2015) (3)
- Gray-matter alterations in pain processing brain structures in patients with somatoform pain disorder – a voxel-based morphometric study (2007) (3)
- Spinal cord atrophy in early Huntington's disease (2014) (3)
- Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012) (2015) (3)
- Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (3)
- Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone (1997) (3)
- Defining a minimal meaningful lesion size in multiple sclerosis (2017) (3)
- Monocyte NOTCH 2 expression predicts IFN-b immunogenicity in multiple sclerosis patients (2018) (3)
- Time to talk about timing – when to start, stop and change anti-migratory drugs in MS (2012) (2)
- Antibodies to aquaporin-4 in patients with a clinically isolated syndrome: analyses from the BENEFIT study (BEtaferon (R) in Newly Emerging multiple sclerosis For Initial Treatment) (2008) (2)
- Repository of the Max Delbrück Center for Molecular Medicine (MDC) (2007) (2)
- Intrathecally Expanding B Cell Clones in Herpes Simplex Encephalitis: A Case Report (2022) (2)
- glycoprotein in multiple sclerosis Identification of a pathogenic antibody response to native myelin oligodendrocyte (2006) (2)
- Association of pregnancies with risk of multiple sclerosis (2022) (2)
- A Novel Bio-Assay To Determine and Characterize the Antibodies to Aquaporin-4 (2014) (2)
- The genetics of natalizumab hypersensitivity (2014) (2)
- Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers (2021) (2)
- No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis. (2011) (2)
- T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis (2020) (2)
- Diagnosis and Management of Neuromyelitis Optica (2011) (2)
- The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis (2007) (2)
- Enriched CD161 CCR6 T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis (2013) (2)
- Cryptococcal Meningitis Reported With Fingolimod Treatment (2022) (2)
- in the Cerebrospinal Fluid of Patients With Multiple Sclerosis (2016) (2)
- Peptide Ligands T Cells and Induce T Cell Responses to Native + Identify Epitopes That Activate Clonotypic CD4 Immunogenicity. I. Use of Peptide Libraries to (2011) (1)
- Optimal Inter-Eye Difference Thresholds in Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis: An International Collaborative Study (P2.160) (2018) (1)
- 18 – Immunopathogenesis of Multiple Sclerosis (2007) (1)
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients (2012) (1)
- The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations (2015) (1)
- Safety and Efficacy of Siponimod (BAF312) in Patients with Relapsing-remitting Multiple Sclerosis: Results from Dose-blinded Extension Phase of BOLD Study (P3.151) (2014) (1)
- Baseline Predictors of Disease Activity in Patients with CIS Treated with Interferon beta-1b in the BENEFIT 11 Trial (P2.121) (2016) (1)
- Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD) (2022) (1)
- Genetic modification of 25(OH)D levels in MS (2014) (1)
- is not associated to multiple sclerosis risk (2019) (1)
- Natalizumab and primary central nervous system lymphoma revisited (2011) (1)
- Longitudinal analysis of autoantibodies, IFN-gamma, and IL-17 in the serum of patients with concomitant NMO and SLE (2015) (1)
- Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis (2022) (1)
- Glatiramer Acetate Complements Anti-CD20-Mediated B-Cell Depletion in Treatment of CNS Autoimmune Disease (P04.124) (2012) (1)
- The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis (2013) (1)
- Author response: Progressive multifocal leukoencephalopathy after fingolimod treatment (2019) (1)
- Cognitive impairment as unusual first manifestation in late-onset relapsing–remitting multiple sclerosis (2012) (1)
- MRI correlates of lesion pathology in T-cell clone mediated mouse experimental autoimmune encephalomyelitis (2006) (1)
- Role of statins in the treatment of multiple sclerosis: an update (2011) (1)
- From specificity to degeneracy to molecular mimicry: Antigen recognition of human autoreactive and pathogen-specific CD4+ T cells (1998) (1)
- Spontaneous Cerebrospinal Fluid Leak With Venous Engorgement Mimicking a Contrast-Enhancing Cervical Mass. (2016) (1)
- [The anti-IgLON5 syndrome in clinical neurology-Report of two cases]. (2022) (1)
- Identification of Target Antigens in CNS Inflammation by Protein Array Technique (2007) (1)
- Fingolimod alters intrathecal B cell maturation in multiple sclerosis patients (2020) (1)
- The 9th International Symposium on Memory and Awareness in Anesthesia (MAA9) (2015) (1)
- CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation (2012) (1)
- Analysis of 103 Hungarian patients with neuromyelitis optica spectrum disease (2014) (1)
- Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination (2023) (1)
- CSF Protein Concentration Shows No Correlation With Brain Volume Measures (2019) (1)
- P2R Inhibitors Prevent Antibody-Mediated Complement Activation in an Animal Model of Neuromyelitis Optica (2022) (1)
- Impact of interferon-beta and glatiramer acetate on the expression of genes involved in immunomodulation and neurorepair (2007) (0)
- OCRELIZUMAB IN PRIMARY PROGRESSIVE MS: THE ORATORIO STUDY (2016) (0)
- to Native Peptide Ligands T Cells and Induce T Cell Responses + CD4 Clonotypic to Identify Epitopes That Activate Immunogenicity. I. Use of Peptide Libraries (1999) (0)
- T cell responses to the inward rectifying potassium channel KIR4.1 in multiple sclerosis patients (2014) (0)
- Surface expression of CXCR 4 on circulating CD 133 + progenitor cells is associated with plaque instability in subjects with carotid artery stenosis (2015) (0)
- Combining capture ELISA and in vivo MxA test to detect neutralizing antibodies to interferon-beta in a large cohort of multiple sclerosis patients (2007) (0)
- EVALUATION OF NEUROFILAMENT PROTEIN HEAVY CHAINS IN SERUM AS BIOMARKER FOR PERI-OPERATIVE BRAIN AFTER CAROTID ENDARTERECTOMY (2009) (0)
- Cognitive impairment in MS: are white matter lesions the main driver? (2017) (0)
- Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis (2018) (0)
- Cryptococcal meningitis in a multiple sclerosis patient treated with Dimethylfumarate (2021) (0)
- Longitudinal analysis of autoantibodies, IFN-gamma and IL-17 in the serum of patients with concomitant neuromyelitis optica and SLE (2015) (0)
- Functional differences off binding vs. meutragizing anti-onterferon beta antibodies in MS patients - Assessment of IgG isotypes, titers and affinities (2008) (0)
- Immunoglobulin GM allotypes in multiple sclerosis (reply) (2013) (0)
- Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume (2022) (0)
- Association of retinal layer architecture and the development of neuropsychological deficits in early multiple sclerosis (2017) (0)
- Accumulation of Gadolinium-based Contrast Agents in the Brain Due to Repetitive Contrast-enhanced MRI: Implications for the Use of MRI in the Diagnosis and Follow-up of Multiple Sclerosis Patients? (2016) (0)
- Reply to Dr Pandey (2013) (0)
- The Effect of Natalizumab Therapy On Immune Surveillance of the Central Nervous System in Multiple Sclerosis Patients (2006) (0)
- Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis (2022) (0)
- Pharmacological PrP-Silencing Accelerates CNS Autoimmune Disease Via TCR Signaling (2010) (0)
- Glucocerebrosidase Mutations and Risk (2017) (0)
- Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta (2020) (0)
- attenuator device for at least one electric cable. (2001) (0)
- Sources and functional significance of IL-6 in shaping autoreactive T cell responses in the peripheral immune compartment and the CNS (2014) (0)
- The affinity spectrum of myelin basic protein-reactive T cells (1999) (0)
- to TCR Ligand Potency Within MHC Molecule or Antigenic Peptide Contribution of Individual Amino Acids (1999) (0)
- Neutralizing antibodies and beyond - Combining capture ELISA and in vivo MxA test to monitor IFN beta therapy (2007) (0)
- the Quality of Early Signaling Events in Human T Thresholds for Effector Function Elicitation, and Relationships Among TCR Ligand Potency, (2017) (0)
- Activation of human class-II restricted T cell clones by short peptides (1998) (0)
- Individual TCR Signaling Events Ligands : Relationship to the Quality of Down-Modulation by Peptide : MHC Molecule Serial TCR Engagement and (1999) (0)
- Baseline Results of the Prospective Nationwide Cohort Study in Clinically Isolated Syndromes and Early Multiple Sclerosis of the German Competence Network Multiple Sclerosis and Monocentric Subgroup Analysis of Neuropsychological Findings (P1.392) (2016) (0)
- Clinicopathological features of a fulminant case of acute disseminated encephalomyelitis (2011) (0)
- Active immunization with amyloid-beta 1–42 induces severe memory impairment in healthy mice (2008) (0)
- PO128 Infusion-related reactions with ocrelizumab in rms and ppms (2017) (0)
- Optical coherence tomography and ophthalmological findings in patients with CIS treated with interferon beta-1b: 11-year follow-up in BENEFIT (BENEFIT 11) (2015) (0)
- Th17 Cells Enter Inflamed CNS Parenchyma Independently of VLA-4 Blockade (2014) (0)
- Active immunisation with amyloid-β 1–42 severely impairs memory performance in healthy mice through TLR 2/4-dependent activation of the innate immune system (2009) (0)
- Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2019) 178(1) (262), (S0092867419306798), (10.1016/j.cell.2019.06.016)) (2020) (0)
- Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants. (2022) (0)
- Influence of 25(OH)D levels and genetic variants on disease severity in MS. (2016) (0)
- Exome Array GWAS in 10,000 Germans Identifies Association between MUC22 and Multiple Sclerosis (2015) (0)
- A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS (2016) (0)
- No association of alpha-2 macroglobulin and low density lipoprotein receptor-related protein gene polymorphisms with multiple sclerosis (2000) (0)
- Sequence Homology Identification of Agonist Ligands with No Recognition Based on Peptide Scans Leads to the Cutting Edge: Predictable TCR Antigen (1998) (0)
- CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype (2023) (0)
- The homeostatic chemokine CCL19 is constitutively expressed in the CNS, up-regulated in multiple sclerosis lesions, and is correlated with intrathecal IgG production (2006) (0)
- NEMOS relapse therapy AnnNeurol2015 (2015) (0)
- Genome-wide association analysis in a German multiple sclerosis cohort (2015) (0)
- F.36. Introduction of a Cell-based Assay Against Native Aquaporin-4-High Specificity and Sensitivity for Neuromyelitis Optica (2008) (0)
- Interleukin-8 correlates with the increase of CD133+ progenitor cells after acute cerebral infarction (2010) (0)
- biobanking A consensus protocol for the standardization of cerebrospinal fluid collection and (2009) (0)
- α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets (2014) (0)
- The p150 subunit of dynactin gene in multiple sclerosis (2006) (0)
- First results of a prospective cohort study in clinically isolated syndromes and early multiple sclerosis of the German Competence Network Multiple Sclerosis (2015) (0)
- Retinal ganglion cell loss is associated with future disability worsening in early relapsing–remitting multiple sclerosis (2023) (0)
- articlePrognostic value of the ABCD 2 score beyond short-term follow-up after transient ischemic attack ( TIA )-a cohort study (2015) (0)
- Introducing 8-color flow-cytometry to the routine workup of cerebrospinal fluid (2007) (0)
- Neuropsychological impairment in newly diagnosed early multiple sclerosis: clinical and neuropsychological characterization of a German cohort of 1124 patients (2017) (0)
- Identification of functionally relevant genetic variants associated with multiple sclerosis using deep learning (2019) (0)
- Genetic risk factors are associated with cerebrospinal fluid measures in multiple sclerosis (2014) (0)
- Herpes-Simplex Virus 2: A New Player in Cerebral Vasculitis (P03.259) (2013) (0)
- Shrinking of T2-hyperintense white matter lesions in early multiple sclerosis (2017) (0)
- Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11) (2015) (0)
- Increased concentration of IL-23 and IL-16 in the serum correlate with AQP4-IgG levels in NMO spectrum disorders (2016) (0)
- p75NTR-knockout mice feature increased axonal vulnerability in experimental autoimmune encephalomyelitis (2007) (0)
- Degeneracy in T-cell antigen recognition (2001) (0)
- Case report: myositis in a patient with LGL leukemia (2004) (0)
- A 50 kb LD block in the CLEC16A gene is highly associated with multiple sclerosis in a German population (2014) (0)
- The Paroxysmal Disorders (2011) (0)
- Genetic Determinants of IgG Synthesis in the Cerebrospinal Fluid of Patients with Multiple Sclerosis (S20.006) (2012) (0)
- Unexpected role of neutrophil granulocytes during both murine and human central nervous system autoimmunity (2017) (0)
- TMIC-49. POTASSIUM CHANNEL KIR4.1 AND GLUTAMINE SYNTHETASE ARE DYSREGULATED IN GLIOMA (2017) (0)
- The Role of B Cells in Multiple Sclerosis (2013) (0)
- Inward rectifying potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease (2013) (0)
- Lesion location across diagnostic regions in multiple sclerosis (2023) (0)
- Disease specific cerebrospinal fluid investigations (2011) (0)
- Antibodies Against the Inward Rectifying Potassium Channel KIR4.1 Precede the Onset of Multiple Sclerosis (S53.007) (2014) (0)
- Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort (2018) (0)
- Complex antibody profiling to predict clinical outcome in childhood ADS (2014) (0)
- Exome-based gene panel analysis in a cohort of acute juvenile ischemic stroke patients:relevance of NOTCH3 and GLA variants (2022) (0)
- Cytoimmunological changes and treatment response in major depression (2004) (0)
- Investigation of novel type 1 diabetes loci in multiple sclerosis (2009) (0)
- NK cell peak after seizures (2007) (0)
- MRI results in patients with CIS treated with interferon beta-1b: 11-year follow up in BENEFIT (BENEFIT 11) (2015) (0)
- B cell responses in HIV infection of the central nervous system (2006) (0)
- Toscana Virus Meningoencephalitis in Upper Bavaria. (2022) (0)
- The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study (2023) (0)
- Regulation of the PD-1/PD-L1 axis in relapsing-remitting Multiple Sclerosis (P2-3.001) (2023) (0)
- THE NEUROCHEMICAL SIGNATURE OF ALZHEIMER'S DISEASE IN COGNITIVELY HEALTHY CONTROLS AND PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE (2014) (0)
- Novel Multiple Sclerosis Genetic Risk Factors Are Involved in Epigenetic Regulation (S37.006) (2016) (0)
- Antibodies to Epstein-Barr virus and myelin oligodendrocyte glycoprotein in childhood inflammatory demyelinating diseases of the central nervous system (2009) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- Herpes-Simplex Virus 2: A New Player in Cerebral Vasculitis (2013) (0)
- Immunopathogenesis of Multiple Sclerosis: Overview (2007) (0)
- Genetic variants are major determinants of cerebrospinal fluid antibody levels in multiple sclerosis (2015) (0)
- Progressive Loss of Cardiac Sympathetic Innervation in Parkinson’s Disease (2002) (0)
- Differential Loss of KIR4.1 on Oligodendrocytes and Astrocytes in Multiple Sclerosis Lesions (S21.003) (2013) (0)
- DGN-(German Society for Neurology)-Congress 2012-5000 Neurologists explore new Ways for the Prevention and Therapy of Brain Diseases (2012) (0)
- Associations of global and regional white matter lesion load with anxiety and fatigue in multiple sclerosis (2015) (0)
- Sa.24. TCR-β Fingerprinting in Single T-Cells; a New High Throughput Method (2006) (0)
- The impact of CD8+ T-cell subsets on HIV replication in the cerebrospinal fluid (2007) (0)
- Author ' s response to reviews Title : Transcranial Doppler ultrasonography predicts cardiovascular events after transient ischemic attack Authors : (0)
- Cluster of Guillain-Barré Syndrome Associated with HLA DQB1*05:01 and the Occurrence of Anti-Ganglioside and Sulfatide Antibodies (P3.143) (2016) (0)
- Author response to Lalive et al. (2018) (0)
- Plasmapheresis therapy in children with inflammatory demyelinating disorders of the CNS (2011) (0)
- Late Breaking News (2015) (0)
- Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia. (2019) (0)
- Cognitive impairment as unusual first manifestation in late-onset relapsing–remitting multiple sclerosis (2012) (0)
- The affinity spedrum of myelin basic protein-reactive T cells (1999) (0)
- Status quo in secondary stroke prevention (2008) (0)
- Reply (2010) (0)
- Intrathecal immunoglobulin synthesis as a predictive marker for disability progression in multiple sclerosis (2017) (0)
- P64 MOBILIZATION OF CD133+ PROGENITOR CELLS AND ITS CORRELATION TO INTERLEUKIN-8 IN ACUTE CEREBRAL INFARCTION (2010) (0)
- Progressive multifocal leukoencephalopathy after fi ngolimod treatment (0)
- Treatment of severe childhood Multiple Sclerosis with plasmapheresis (2011) (0)
- Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11) (2016) (0)
- Anti-CD20 B-Cell Depletion Increases the Frequency of Regulatory T Cells, but Enhances Monocyte Reactivity in Multiple Sclerosis and Neuromyelitis Optica (2011) (0)
- Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis (2023) (0)
- Longitudinal serological and clinical data indicate that SLE activity may contribute to NMO relapses (2014) (0)
- Tissue damage within normal-appearing white-matter in early MS: quantification by the ratio of T1/T2-weighted MR image intensities (2015) (0)
- Contents Vol. 66, 2011 (2011) (0)
- Su.68. The Relation of Viral Load and Leukocyte Subsets in the Cerebrospinal Fluid of Hiv Infected Individuals (2006) (0)
- Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis (2023) (0)
- Is Systemic Thrombolysis Justified in Patients with Ischemic Stroke and Recent Dental Extraction? (P03.009) (2012) (0)
- PO127 Composite confirmed disability progression in oratorio (2017) (0)
- Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases (2019) (0)
- [New approaches in research of therapy of multiple sclerosis]. (2001) (0)
- A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases (2023) (0)
- Imaging of pathological effects of aquaporin-4 specific antibodies ex vivo and in vivo (2014) (0)
- Bedämpfungseinrichtung for at least one electrical cable (2001) (0)
- MRI-plaqueimaging detects carotid plaques with a high risk for future cerebrovascular events (2009) (0)
- Bony Stroke: Ischemic Stroke Caused by Mechanical Stress on Brain Supplying Arteries From Anatomical Bone or Cartilage Anomalies (2023) (0)
- Integrin and IL-16/IL-23 biomarker clusters differentiate AQP4-IgG+ NMO spectrum disorders, relapsing-remitting MS and healthy controls (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernhard Hemmer?
Bernhard Hemmer is affiliated with the following schools:
